U.S. to resume use of J&J COVID-19 vaccine immediately
The U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration said in a joint statement that health systems and vaccine recipients would be warned of the risk of a potentially fatal syndrome involving severe blood clots and low platelets.
Written By:
Manas Mishra and Julie Steenhuysen / Reuters | 12:35 pm, Apr. 23, 2021 ×
A vial and sryinge are seen in front of a displayed Johnson & Johnson logo in this illustration taken Jan. 11, 2021. (REUTERS/Dado Ruvic/Illustration/File Photo)
April 23 (Reuters) - The United States can resume use of Johnson & Johnson s COVID-19 vaccine immediately, top health regulators said on Friday, ending a 10-day pause to investigate the vaccine s link to extremely rare but potentially deadly blood clots.
Balloon Juice | LOL Mario s Kid balloon-juice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balloon-juice.com Daily Mail and Mail on Sunday newspapers.
Advisory panel recommends resumed J&J vaccine use in US
Updated / Friday, 23 Apr 2021
23:01
Top US health officials have said they hope for a quick return of the convenient one-shot vaccine following the panel meeting
Use of Johnson & Johnson s Covid-19 vaccine should be resumed in the United States, advisers to US health regulators have said, after weighing evidence of the shot s link to extremely rare but potentially deadly blood clots.
The recommendation paves the way for J&J s shot to begin going into arms again in the United States, once they are confirmed by regulators.
The US Centers for Disease Control and Prevention and the US Food and Drug Administration paused its use last week in order to review reports of the blood clot condition accompanied by low blood platelets.